Related Experiment Video
Updated: May 12, 2025

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Vitamin D deficiency enhances platelet activation and thrombosis by regulating VDR/Akt pathway based on platelet
Shanshan Nie1, Peng Huang2, Huan Niu2
1Center of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China; Department of Cardiovascular Disease, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, 450000, China.
Scope:
Vitamin D deficiency (VDD) is a worldwide pandemic. Pleiotropic effects of vitamin D beyond calcium homeostasis have been shown. However, the direct impact of VDD on platelet reactivity and thrombus formation, as well as the underlying mechanisms, remain vague.
Methods And Results:
427 acute coronary syndrome patients undergoing percutaneous coronary intervention were enrolled in the study. The platelet proteome was analyzed using a four-dimensional data-independent assessment. Platelet function and FeCl3-induced carotid artery thrombosis were investigated in the VDD rats. Lower vitamin D quartiles (<16.45 ng/mL) were independently associated with high on-treatment platelet reactivity (adjusted OR 4.21 [95 %CI 1.74-10.15, P = 0.001]). Differential proteins were related to platelet activation, PI3K-Akt pathway, and Vitamin D receptor (VDR). Platelet function was enhanced in diet-induced VDD rats. VDD accelerated FeCl3-induced carotid artery thrombosis and shortened tail bleeding time. Mechanism studies revealed that VDD may exert its destructive effect by inactivating the VDR and augmenting p-Akt expression.
Conclusion:
VDD was independently related to high on-treatment platelet reactivity among acute coronary syndrome patients undergoing percutaneous coronary intervention. VDD enhanced platelet function and thrombosis by activating the VDR/Akt signaling pathway. Vitamin D replacement therapy could partly reverse these changes, making it a theoretical basis for the prevention of VDD-related thrombotic disease.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

